Breaking News: New FDA Approval for Darolutamide

Patients with metastatic hormone-sensitive prostate cancer have an additional treatment option.

Learn More

Patient Talking to Doctor- Expanded FDA Approval Means More Treatment Options

Keep Dad in the Game

Since 1996‚ MLB and PCF have partnered together to fight prostate cancer.

Learn More

June 30 Webinar: Genetic & Biomarker Testing

Genetic and biomarker testing can provide critical information on your specific prostate cancer. Learn who should get tested and what it can mean for your care.

Register

PCF Webinar Series- Genetic & Biomarker Testing

Accelerating a Healthier Future Through AI

At the 2025 Milken Institute Global Conference, PCF’s President & CEO, Gina Carithers, led a powerful discussion on how AI is transforming the future of health.

Watch Now

Accelerating a Healthy Future Through AI- Global Conference panel speakers

From Checkmate to Road Trip

Veteran Rodolfo LLobet was running out of options. Innovative PCF-funded science offered a new treatment…and hope to him and his family.

Learn More

Rodolfo LLobet

The Prostate Cancer Foundation has worked since 1993 to end death and suffering from prostate cancer through research, providing effective treatments for patients and families.

About PCF  

Ways to Take Action

Our Work

Patient Support

The Latest

George Zhao, MD

“The Prostate Cancer Foundation Young Investigator Award was crucial in jumpstarting my career. It not only funded important research but also helped me secure a physician-scientist position.”

The Work We Fund

Benny Johnson, Jr.

“Meeting Dr. King made it a little more lighter. When I met her, she told me some things we can do because in between that, my sexual situation was up and down, and more down than up at that particular point. So we figured we had to do something about that.”

Sexual Health